Target intelligence / Profile preview

Glutamate ionotropic receptor AMPA type subunit 2-containing receptor complex (GluA2-containing AMPAR)

Target
GluA2-containing AMPAR
Molecular classification
Ionotropic glutamate receptor, Ligand-gated ion channel
01

Overview

The GluA2-containing AMPA receptor is a subtype of ionotropic glutamate receptor that mediates the majority of fast excitatory synaptic transmission in the central nervous system [Traynelis et al., 2010, Pharm Rev]. The inclusion of the GluA2 subunit, particularly in its Q/R edited form, is a primary determinant of the receptor's biophysical properties, rendering the channel impermeable to calcium ions and protecting neurons from excitotoxicity [Isaac et al., 2007, Neuron]. Transmembrane AMPA receptor regulatory proteins (TARPs), specifically TARP γ-2 (also known as Stargazin), act as essential auxiliary subunits that regulate the trafficking of these receptors to the postsynaptic membrane and modulate their gating kinetics [Jackson & Nicoll, 2011, Neuron]. Dysregulation of GluA2-containing receptors is implicated in various neurological disorders, including epilepsy, amyotrophic lateral sclerosis (ALS), and neurodegenerative diseases like Alzheimer's [Kwak & Weiss, 2006, Neurobiol Dis; Guntupalli et al., 2016, Mol Brain]. Pharmacological targeting of these receptors often involves non-competitive antagonists or allosteric modulators, with some newer compounds specifically targeting the interaction between the receptor and its TARP subunits to achieve regional or functional selectivity [Kato et al., 2016, Nature Medicine]. Understanding the stoichiometry and auxiliary protein associations of these receptors is crucial for developing therapies that balance efficacy with minimized side effects such as sedation or motor impairment [French et al., 2012, Neurology].

Other names
GRIA2-containing AMPA receptorGluR2-containing AMPA receptorStargazin-associated AMPA receptorGluA2/TARP γ-2 complexAMPA receptor subunit 2 complex
02

Mechanism of action

Non-competitive antagonism of the AMPA receptor [French et al., 2012, Neurology]; TARP-dependent negative allosteric modulation [Kato et al., 2016, Nature Medicine]; Positive allosteric modulation [Lynch, 2006, Ampakines].

03

Biological functions

Fast excitatory neurotransmissionSynaptic plasticityRegulation of calcium permeabilityLong-term potentiationLong-term depression
04

Disease associations

EpilepsyAmyotrophic lateral sclerosisAlzheimer's diseaseIschemic strokeNeuropathic painSchizophrenia
05

Safety considerations

DizzinessSomnolenceAtaxiaPsychiatric adverse eventsCognitive impairmentSeizure risk upon withdrawal
06

Interacting drugs

Perampanel

4 more in the full profile.

07

Biomarkers

[11C]K-2 PET imaging [Miyazaki et al., 2020, Nat Med]GluA2 subunit mRNA/protein levels [UniProt P42262]

Beyond the preview

Go deeper on Glutamate ionotropic receptor AMPA type subunit 2-containing receptor complex (GluA2-containing AMPAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate ionotropic receptor AMPA type subunit 2-containing receptor complex (GluA2-containing AMPAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call